Stoichiometry of the heteromeric nicotinic receptors of the Renshaw cell (CROSBI ID 251191)
Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija
Podaci o odgovornosti
d'Incamps , Boris Lamotte ; Zorbaz, Tamara ; Dingova , Dominika ; Krejci , Eric ; Ascher , Philippe
engleski
Stoichiometry of the heteromeric nicotinic receptors of the Renshaw cell
Neuronal nicotinic acetylcholine receptors (nAChRs) are pentamers built from a variety of subunits. Some are homomeric assemblies of α subunits, others heteromeric assemblies of α and β subunits which can adopt two stoichiometries (2α:3β or 3α:2β). There is evidence for the presence of heteromeric nAChRs with the two stoichiometries in the CNS, but it has not yet been possible to identify them at a given synapse. The 2α:3β receptors are highly sensitive to agonists, whereas the 3α:2β stoichiometric variants, initially described as low sensitivity receptors, are in fact activated by low and high concentrations of ACh. We have taken advantage of the discovery that two compounds — NS9283 and Zn — potentiate selectively the 3α:2β nAChRs to establish (in mice of either sex) the presence of these variants at the motoneuron-Renshaw cell (MN-RC) synapse. NS9283 prolonged the decay of the two- component EPSC mediated by heteromeric nAChRs. NS9283 and Zn also prolonged spontaneous EPSCS involving heteromeric nAChRs, and one could rule out prolongations resulting from AChE inhibition by NS9283. These results establish the presence of 3α:2β nAChRs at the MN-RC synapse. At the functional level we had previously explained the duality of the EPSC by assuming that high ACh concentrations in the synaptic cleft account for the fast component and that spillover of ACh accounts for the slow component. The dual ACh sensitivity of 3α:2β nAChRs now allows to attribute to these receptors both components of the EPSC.
nicotinic acetylcholine receptors (nAChRs), NS9283, motoneuron-Renshaw cell (MN-RC) synapse, AChE inhibition
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
38 (21)
2018.
4943-4956
objavljeno
0270-6474
10.1523/JNEUROSCI.0070-18.2018
Povezanost rada
Kemija, Biologija, Farmacija